CVS Disclosed HIV-Positive Status of Thousands
  • Super Lawyers
  • Million Dollar Advocates Forum
  • AV Peer Review Rated
  • AVVO Rating 10.0
  • Best Law Firms US News
  • The Best Law Firms 2020

Lawsuit Filed Regarding CVS’ Disclosure of the HIV-Positive Status of Thousands of Ohioans

Was Your HIV-Positive Status Unlawfully Revealed By This Letter?

Persons living with HIV are frequently subject to discrimination and stigma based on their condition. Yet, in the late summer of 2017, CVS mailed a letter that disclosed the HIV-positive status of approximately 6,000 patients who were part of the Ohio HIV Drug Assistance Program. Medical privacy is important for all patients, but especially for those with HIV.

Despite the legal need to protect the information of these patients, CVS did not make sure that only the intended recipient could see the contents of the notice by printing the HIV-positive status and name of the recipient on the envelope. By doing so, anyone who came in contact with the letter, including family members, significant others, roommates, co-workers, people who receive and distribute mail at offices or homes, postal workers, letter carriers, and more could clearly see this information and now know this private and protected information.

That’s why the class action attorneys at Meyer Wilson, Lambert Law, and Kaplan Fox have filed a lawsuit in federal court in Columbus seeking to hold CVS responsible.

If you or someone you know is or has been a member of the Ohio HIV Drug Assistance Program and may have received a mailing from CVS in the summer of 2017, we invite you to contact us today. You may be entitled to money damages.

Read more on our blog.

Ready to Speak with an Attorney?

Schedule a Free Consultation With Our Firm By Calling (888) 592-8455
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.